Dr. Aaron Bussey, MD (he/him) is an Endocrinologist in Alcoa, TN with over 16 years of experience. What is your opinion of Dr. Aaron Bussey, MD? Rate this provider below so other people can make informed decision.
Over 16 Years of Experience
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Aaron Bussey, MD has received over $107,217 which includes payments from the following companies:
$65,247.97 from sanofi-aventis U.S. LLC
$17,043.01 from Takeda Pharmaceuticals America, Inc.
$6,777.78 from Tandem Diabetes Care, Inc.
$5,638.38 from AstraZeneca Pharmaceuticals LP
$2,548.95 from Novo Nordisk Inc
$1,543.44 from LILLY USA, LLC
$1,172.69 from Abbott Laboratories
$641.33 from Dexcom, Inc.
$638.34 from Medtronic MiniMed, Inc.
$600.67 from Janssen Pharmaceuticals, Inc
$568.40 from INSULET CORPORATION
$560.20 from Takeda Pharmaceuticals U.S.A., Inc.
$542.96 from Boehringer Ingelheim Pharmaceuticals, Inc.
$504.40 from Amgen Inc.
$447.07 from MannKind Corporation
$289.43 from GlaxoSmithKline, LLC.
$280.27 from Merck Sharp & Dohme Corporation
$275.28 from Amarin Pharma Inc.
$257.02 from Shire North American Group Inc
$178.54 from Valeritas, Inc.
Payments received by Dr. Aaron Bussey, MD were from the following categories:
$80,378.00 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!